42T.SI - The Trendlines Group Ltd.
| Previous Close | 0.0880 |
| Open | 0.0880 |
| Bid | 0.0880 x 0 |
| Ask | 0.0890 x 0 |
| Day's Range | 0.0870 - 0.0900 |
| 52 Week Range | 0.0760 - 0.1090 |
| Volume | 3,445,200 |
| Avg. Volume | 1,843,520 |
| Market Cap | 63.4M |
| Beta (3Y Monthly) | 0.51 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0080 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Fidmi Medical Receives FDA Regulatory Clearance for Low-profile Enteral Feeding Device
CAESAREA, Israel , Oct. 16, 2019 /PRNewswire/ -- Fidmi Medical Ltd. a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced today that it received ...
- PR Newswire
Gordian Surgical's Closure System Used in Panama by PanaFarma
PanaFarma wins tender to supply social security hospitals with closure system for two years. ("Trendlines") (42T.SI) (TRNLY), announced today that its exclusive distributor in Panama - PanaFarma - has won the tender to supply Panama's social security hospitals with the TroClose™1200 access-closure system for a two-year period. As a commercial-stage medical device company with growing international sales of its innovative TroClose 1200 access-closure system for laparoscopic surgery, this translates to the sale of a few thousand products to Panama.
- PR Newswire
FruitSpec Closes $4 Million Investment From AgVentures & Hubei Forbon Technology for Its Yield Estimation Solution
MISGAV, Israel, Sept. 24, 2019 /PRNewswire/ -- FruitSpec, a portfolio company of The Trendlines Group Ltd. (42T.SI) (TRNLY), is pleased to announce that it has completed an investment round of $4 million. Investors included AgVentures, a South African agtech investment company and Hubei Forbon Technology Co. Ltd., China. Inaccurate fruit yield estimation from an early stage (especially in green fruit) remains a key problem in the food chain.
- PR Newswire
OrthoSpin Receives FDA Regulatory Clearance
MISGAV, Israel , Sept. 18, 2019 /PRNewswire/ -- OrthoSpin Ltd. a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced today that it received regulatory ...
- PR Newswire
MetoMotion Receives $1.5 Million Investment From Netherlands-based Strategic Partner for Its Greenhouse Robotic Worker (GRoW)
MISGAV, Israel, July 31, 2019 /PRNewswire/ -- MetoMotion, a portfolio company of The Trendlines Group Ltd. (42T.SI) (TRNLY), announced that it has completed an investment round of $1.5 million, which was led by a leading Netherlands-based company in the greenhouse industry. Greenhouses today face two critical problems, both of which contribute to economic damage: (1) increasing labor shortages and (2) a lack of skilled labor. With labor costs accounting for up to 50% of total greenhouse production costs, growers are looking to technology to solve the labor crunch.
- PR Newswire
The Trendlines Group Receives SGD10.88 Million (USD8 million) Investment
MISGAV, Israel, July 22, 2019 /PRNewswire/ -- The Trendlines Group Ltd. ("Trendlines") (42T.SI) (TRNLY) today announced that it has signed a Subscription Agreement with Librae Holdings Limited ("LH"), for an SGD10.88 million (USD8 million) investment. London-based discretionary beneficiary to the trust that is sole shareholder of LH, Mr. Vincent Tchenguiz, is best known for his multi-billion-pound real estate portfolio. In the past three years, he has diversified his investments with increased focus on biotechnology and planet related technologies and built a USD350 million technology venture capital portfolio managed by a strong tech investment team1.
- CNW Group
Life Science Company Live Investor Presentations Now Available for On-Demand Viewing
Life Science Company Live Investor Presentations Now Available for On-Demand Viewing
- PR Newswire
Bayer Trendlines Ag Innovation Fund to Co-invest With Trendlines in New Company
MISGAV, Israel and MONHEIM, Germany, July 10, 2019 /PRNewswire/ -- The Bayer Trendlines Ag Innovation Fund, set up by Bayer CropScience LLC ("Bayer") and The Trendlines Group Ltd. ("Trendlines") (42T.SI) (TRNLY), announced that it established EcoPhage Ltd. ("EcoPhage"), a new company focused on discovering and developing environmentally friendly products for disease control in agriculture. The Company will leverage a disruptive technology for using bacteriophages, viruses that attack bacteria, for crop protection.
- PR Newswire
Life Science Company Live Investor Conference July 11th
Life science company executives will share vision and answer audience questions at VirtualInvestorConferences.com NEW YORK , July 9, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the ...
- PR Newswire
The Trendlines Group Ltd. to Webcast Live at VirtualInvestorConferences.com July 11th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com MISGAV, Israel , July 9, 2019 ...
- PR Newswire
ProArc Medical Awarded $2.2 Million European Union Grant
TEL AVIV, Israel, July 2, 2019 /PRNewswire/ -- ProArc Medical ("ProArc"), announced that it received a $2.2 million grant from the prestigious Horizon 2020 program as a part of the European ...
- PR Newswire
Limaca Medical Initiates First-in-Human Study of Biopsy Device for Improved Tumor Diagnosis
MISGAV, Israel , May 16, 2019 /PRNewswire/ -- Limaca Medical Ltd. ("Limaca"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced the ...
- PR Newswire
BioFishency Raises $2.4 Million for its Water Treatment Systems for Aquaculture
MISGAV, Israel, March 27, 2019 /PRNewswire/ -- BioFishency Ltd. ("BioFishency" or "the Company"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (42T.SI) (TRNLY), announced that it has completed an investment round of $2.4 million. The primary investors in the round were a private investor from China, Aqua-Spark, a global investment fund based in the Netherlands, and The Trendlines Group. BioFishency is an aquaculture solutions provider focused on dramatically increasing growers' productivity and sustainability through its innovative technologies and extensive knowhow.
- PR Newswire
BioFishency Raises $2.4 Million for Its Water Treatment Systems for Aquaculture
MISGAV, Israel, March 27, 2019 /PRNewswire/ -- BioFishency Ltd. ("BioFishency" or "the Company"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (42T.SI) (TRNLY), announced that it has completed an investment round of $2.4 million. The primary investors in the round were a private investor from China, Aqua-Spark, a global investment fund based in the Netherlands, and The Trendlines Group. BioFishency is an aquaculture solutions provider focused on dramatically increasing growers' productivity and sustainability through its innovative technologies and extensive knowhow.
- PR Newswire
Omeq Medical Penetrates Epidural Market in China Through US$3 Million Funding and Commercialization Agreement With Pharos Medical
Omeq Medical Ltd. ("Omeq"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (42T.SI) (TRNLY), announced today that it has signed an investment and commercialization agreement for its smart epidural device with Pharos Medical ("Pharos"), a Shanghai-based manufacturer and distributor of medical devices. Omeq has developed a single-use, smart epidural device for safe, accurate epidural injections to thwart inaccurate needle placement - estimated at up to 30% of initial injections.
- PR Newswire
Successful First in Human for ZygoFix's Spinal Facet Joint Fixation System
MISGAV, Israel , Dec. 10, 2018 /PRNewswire/ -- ZygoFix Ltd. ("ZygoFix"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced the successful ...
- PR Newswire
The Trendlines Group Reports Record 2018 Third Quarter Profit Portfolio Value Exceeds US$102 Million (SGD141 Million)
MISGAV, Israel , November 12, 2018 /PRNewswire/ -- The Trendlines Group Ltd. (the " Company " and together with its subsidiaries, "Trendlines" or the " Group "), a leading ...
- PR Newswire
FruitSpec Completes Successful Field Studies
OTCQX: TRNLY) announced that it completed successful field studies with its solution for fruit yields estimates/projections. The trials, which used FruitSpec's hyperspectral machine vision technology, resulted in estimates that were more than 90% accurate. No technology available today provides accurate yield estimations early in the season, which impacts key business decisions made along the entire fruit value chain.